IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION

2:16-md-02724

Class Action, Multi-district Litigation

October 31, 2017
State AGs Triple Size Of Generic Price-Fixing Litigation

The 46 attorneys general accusing six drug companies of conspiring to fix the price of two generic drugs said Tuesday they're asking a Pennsylvania federal court for permission to massively expand their suit by targeting 12 more drug companies, 13 more drugs, and Mylan and Emcure executives.
June 02, 2017
6 Suits Say Mylan, Others Rigged Generic Drug Prices

Mylan Inc., Fougera Pharmaceuticals Inc., Par Pharmaceuticals Inc. and other drugmakers conspired to jack up the prices of certain generic muscle relaxers, skin creams, antidepressants and blood pressure drugs, a Northeast U.S. pharmacy operator said in six separate antitrust lawsuits filed on Thursday as part of multidistrict litigation in Pennsylvania federal court.
May 23, 2017
Generic Drug Price-Fixing MDL Fuels Worries For Defendants

The multidistrict litigation over alleged price-fixing of generic drugs recently consolidated in Pennsylvania's Eastern District has the potential to emerge as one of the thorniest court fights in the country, and some observers have raised concerns that the numerous defendants could make it harder for individual companies to avoid getting more deeply embroiled in the litigation.